J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Read full article: J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disordersJohnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies.